Clinical Trial

Nanofat Injection and Fractional CO2 Laser for Post-Traumatic Atrophic Scars

Study acronym: NANOCO2-PTS
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Post-traumatic atrophic scars are characterized by skin depressions caused by loss of collagen and can lead to cosmetic and psychological concerns. Several treatment options have been proposed, including fractional carbon dioxide (CO2) laser resurfacing and autologous nanofat grafting, both of which may improve scar appearance through skin remodeling and regeneration. This prospective comparative study evaluates the safety and efficacy of fractional CO2 laser alone, autologous nanofat injection alone, and combination therapy in patients with post-traumatic atrophic scars. Sixty participants were assigned to one of three treatment groups and were assessed using the Vancouver Scar Scale, physician global assessment, patient satisfaction, dermoscopic examination, and histopathological evaluation. The study aims to determine whether combining fractional CO2 laser and nanofat injection provides superior clinical and regenerative outcomes compared with either treatment alone while maintaining an acceptable safety profile.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-25.
Trial Details
NCT Number NCT07679217
Lead Sponsor Tanta University
Conditions Post-Traumatic Atrophic Scar, Atrophic Scar, Scar
Enrollment 60 participants
Start Date 2026-06-28
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-02